|
|
|
|
Science Sparks @ ACTREC
|
 04 May 2026 |
Vol. No. 15 ; Issue No.733 |
|
|
Publications
|
|
1. Mir MA, Bhat A, Macha MA, Mehraj U, Verma N, Masoodi G (2026). p53 in cancer therapy: the impact of mutations on the genome guardian. Frontiers in Immunology.
2. Kamal A, Sheregare Y, Patkar C, Markam M, Deolikar R, Sriraman N, Seth A, Jaiswal M, Khadilkar RJ (2026). Bendless-mediated K63 ubiquitination modulates cellular signalling to Cell Communication and Signaling regulate Drosophila hematopoiesis. Cell Communication Signaling.
3.
Mehta D, Paradkar A, Rekhi B, Nayak P, Mohanty B, Chaudhari P, Gera P, Rane S, Chaturvedi P, Waghmare SK (2026). Histone methylation defines c-Jun/Sox2/Hif1α axis that controls stemness and tumor progression in squamous cell carcinoma. Nature Communications
4. Sinukumar S, Kazi M, Damodaran D, Prabhu A, Piplani S, Naik S, Sankaralingam D, Bhatt A (2026). Ca125 KELIM as a Potential tool for predicting hyperthermic intraperitoneal chemotherapy (HIPEC) benefit at interval cytoreductive surgery for advanced epithelial ovarian cancer-A propensity score-matched analysis. Journal of Surgical Oncology.
5. Sarit S, Mishra S, Patil S, Patsani P, Mhamane S, Dash B, Nayak L, Swain S, Budukh A, Chaturvedi P, Gupta S(2026). Oral premalignant disorders in housekeeping and security staff of a higher education institute in Bhubaneshwar, Odisha state, India. Journal of Family Medicine and Primary Care. 15(3):1141-1148.
6. Panzade G, Mahajan AA, Panda SP, Chowdhury U, Iyer RK, Ghosh S, Koley M, Bhattacharya A, Chatterjee A, Dey A, Sarkar C, Chowdhury A, Chatterjee B, Das S, Das S, Bandyopadhyay S, Rajendran RL, Gangadaran P, Ahn BC, Jha SK (2026). Emerging nanoimmunotherapeutic strategies for breast cancer. Discovery Oncology.
7. Chakrabarty N, Krishnan N, Mahajan A, Dadlani T, Shah M, Deshmukh A, Singh A, Laskar SG, Pantvaidya G, Shetake A, Rane SU, Bal M, Nair D, Nair SV, Menon N, Patil A, Noronha V, Prabhash K, Chaturvedi P (2026). MRI-based tumor signatures as prognostic biomarkers in oral tongue squamous cell carcinoma. Frontiers in Oncology. 216:1809223.
8. Das D, Tambe M, Rajak J, D'Silva SZ (2026). Identification of the novel HLA-B*44:03:02:08 allele in an Individual from eastern India. HLA. 107(4):e70713.
Thesis
Priyanka Joshi. 2025. Defining the role of cell signaling in head and neck cancer stem cells.
(LIFE09201804006) (Guide: Dr. Sanjeev Waghmare)
|
|
|
|
|
Interesting Reads
|
|
Winkler F, Heuer S, Althammer F, Augustin H, Beleggia F, Demir IE, Koenig J, Kuner R, Kuner T, Loges S, Platten M, Reinhardt HC, Rich JM, Sahm F, Stassart RM, Thiel V, Trumpp A, Venkataramani V, Wick W, Karreman MA(2026). Cancer neuroscience: The past, the present, and the road ahead. Cell. 189(8):2464-2489.
|
|
|
Video of the Week
|
|
| Cancer Metastatis: A Clinician’s Perspective |
|
| |
|
|
| |
|
|
|
|
Do You Know?
In 1975, Georges Kohler and Cesar Milstein developed the technique (hybridoma technology) for producing monoclonal antibodies against defined proteins
|
|
|
|
Cancer News
|
| |
|
First-ever 3D view shows how killer T cells destroy cancer.
|
|
Sciencedaily, 30/04/2026
|
|
First-ever 3D view shows how killer T cells destroy cancer. Sciencedaily, 30/04/2026
The body’s “killer” T cells don’t just attack—they strike with astonishing precision, forming a tiny, highly organized contact zone that lets them destroy dangerous cells without harming their neighbors
...
|
| |
|
Nerves in skin can slow melanoma growth
|
|
Eurekalert, 29/04/2026
|
|
In the study,the researchers used mouse models of the skin cancer melanoma to examine the presence and the effects of peripheral nerves that grow into tumors....
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
2026 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)
|
|
